GBp 3.75
(-2.6%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | 19.00 | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | 19.00 | - |
Operating Expenses | 770 Thousand | 708 Thousand | 1.02 Million | 712 Thousand | 35 Thousand | 68 Thousand |
Selling, General and Administrative Expenses | 771 Thousand | 428 Thousand | 501 Thousand | 324 Thousand | 153 Thousand | 432 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -1000.00 | 280 Thousand | 521 Thousand | 388 Thousand | -118 Thousand | - |
Cost and Expenses | 770 Thousand | 708 Thousand | 1.02 Million | 712 Thousand | 35 Thousand | 68 Thousand |
Operating Income | -770 Thousand | -708 Thousand | -1.02 Million | -712 Thousand | -65 Thousand | -438 Thousand |
Interest Expense | - | 67 Thousand | - | - | 417 Thousand | - |
Income Tax Expense | - | 149 Thousand | -1000.00 | -38.00 | 136 Thousand | - |
Earnings before Tax | -61 Thousand | -924 Thousand | -1.02 Million | -712 Thousand | -482 Thousand | -83 Thousand |
Net Income | 50 Thousand | -1.07 Million | -1.02 Million | -712 Thousand | -618 Thousand | -83 Thousand |
Earnings Per Share Basic | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Earnings Per Share Diluted | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 319.17 Million | 265.92 Million | 261.47 Million | 261.47 Million | 261.47 Million | 52.03 Million |
Weighted Average Shares Outstanding (Diluted) | 456.54 Million | 265.92 Million | 261.47 Million | 261.47 Million | 261.47 Million | 52.03 Million |
Gross Margin | - | - | - | - | 1.00 | - |
EBIT Margin | - | - | - | - | -3421.05 | - |
Profit Margin | - | - | - | - | -32.52 Thousand | - |
EBITDA | - | - | - | -674 Thousand | -20 Thousand | -422 Thousand |
Earnings Before Tax Margin | - | - | - | - | -3421.05 | - |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 313.09 Thousand | 61 Thousand | 296.88 Thousand | 324.36 Thousand | 708 Thousand | 281.87 Thousand |
Selling, General and Administrative Expenses | 313.09 Thousand | - | 296.88 Thousand | 324.36 Thousand | - | 281.87 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | 280 Thousand | - |
Cost and Expenses | 313.09 Thousand | 61 Thousand | 296.88 Thousand | 324.36 Thousand | 708 Thousand | 281.87 Thousand |
Operating Income | -313.09 Thousand | -772 Thousand | -296.88 Thousand | -324.37 Thousand | -708 Thousand | -281.87 Thousand |
Interest Expense | - | - | - | - | 67 Thousand | 48.53 Thousand |
Income Tax Expense | -159.71 Thousand | 711 Thousand | -88.58 Thousand | -0.58 | 149 Thousand | -54.88 Thousand |
Earnings before Tax | -218.21 Thousand | -61 Thousand | 272.14 Thousand | -325.98 Thousand | -924 Thousand | -474.32 Thousand |
Net Income | -58.5 Thousand | 50 Thousand | 360.73 Thousand | -325.98 Thousand | -1.07 Million | -474.32 Thousand |
Earnings Per Share Basic | -0.00 | - | 0.00 | -0.00 | - | -0.00 |
Earnings Per Share Diluted | -0.00 | - | 0.00 | -0.00 | - | -0.00 |
Weighted Average Shares Outstanding | 389.55 Million | 505.05 Million | 286.68 Million | 283.1 Million | 264 Million | 268.93 Million |
Weighted Average Shares Outstanding (Diluted) | 389.55 Million | 456.54 Million | 295.52 Million | 283.1 Million | 264 Million | 268.93 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -218.21 Thousand | - | 272.14 Thousand | -324.36 Thousand | - | -281.87 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
LGHL
MEDICO
MDRNSTL
TNTMF
MMRUBBR-B
BPTR